Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Year range
1.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 632-640, 2021.
Article in English | WPRIM | ID: wpr-888792

ABSTRACT

A phytochemical investigation was carried out on the extract of a medicinal plant Callicarpa nudiflora, resulting in the characterization of five new 3, 4-seco-isopimarane (1-5) and one new 3, 4-seco-pimarane diterpenoid (6), together with four known compounds. The structures of the new compounds were fully elucidated by extensive analysis of MS, 1D and 2D NMR spectroscopic data, and time-dependent density functional theory (TDDFT) calculation of electronic circular dichroism (ECD) spectra, and DFT calculations for NMR chemical shifts and optical rotations.


Subject(s)
Abietanes/isolation & purification , Callicarpa/chemistry , Diterpenes/isolation & purification , Molecular Structure , Phytochemicals/isolation & purification , Plant Leaves
2.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 161-186, 2019.
Article in English | WPRIM | ID: wpr-776895

ABSTRACT

Chimonanthus plants widely distributed in southern area of China, which have a long history of edibles and medicine. Phytochemical investigations have shown that Chimonanthus produced 143 non-volatile constituents, including alkaloids, flavonoids, terpenoids, coumarins and others, which exhibit significant anti-oxidant, anti-bacterial, anti-cancer, anti-inflammatory, antihyperglycemic, antihyperlipidemic and other biological activities. On the basis of systematic reviewing of literatures, this article overviews the non-volatile constituents and pharmacology of Chimonanthus from domestic and foreign over the last 30 years (until June 2018), and may provide a useful reference for the further development of Chimonanthus.


Subject(s)
Animals , Humans , Calycanthaceae , Chemistry , Drugs, Chinese Herbal , Chemistry , Pharmacology , Therapeutic Uses , Toxicity , Medicine, Chinese Traditional , Phytochemicals , Chemistry , Pharmacology , Therapeutic Uses , Toxicity , Phytotherapy
3.
Journal of Jilin University(Medicine Edition) ; (6): 408-411,后插4, 2018.
Article in Chinese | WPRIM | ID: wpr-691588

ABSTRACT

Objective:To report the clinical manifestations of 1 case of intracranial multicentric astrocytoma,and to provide a reference for its clinical diagnosis and treatment.Methods:The clinical data of one patient with intracranial multicentric astrocytomas were retrospectively analyzed and the diagnosis and treatment were summarized,and the relevant literatures were reviewed.Results:The patient was male,25 years old,and admitted to hospital due to the sudden convulsions 1 time 18 d ago.The head MRI scanning and enhanced scanning displayed that the left frontal lobe and corpus callosum knee exited the group of patchy mixed abnormal signals,and the left frontal temporal lobe exited the capsule-like mixed signals.Surgical treatment was performed,and the lesions of the left frontal lobe and corpus callosum knee and left frontal temporal lobe were resected.The difference of the two lesions was observed during the operation(the left frontal and corpus callosum knee lesion was cystic and solid mixed tissue,solid organization accounted for majority,and had internal calcification;the left frontal temporal lobe lesion was cystic and solid mixed tissue,and cystic tissue accounted for the majority).The postoperative pathology showed that the left frontal lobe and corpus callosum knee lesion had locally more intensive cells,and more different cells,and it was diagnosed as astrocytoma(WHO Ⅱ-Ⅲ);the left frontal temporal lobe lesion was diagnosed as astrocytoma(WHO Ⅱ).After operation,the patient recovered well,and it was recommended to continue radiotherapy and chemotherapy.Conclusion:For the patients with intracranial multicentric astrocytomas,active surgical treatment is in favor of prolonging the survival of the patients.Postoperative radiotherapy is still controversial,but chemotherapy should be recommended.

4.
Journal of Jilin University(Medicine Edition) ; (6): 175-178, 2018.
Article in Chinese | WPRIM | ID: wpr-691547

ABSTRACT

Objective:To investigate the diagnosis and treatment of one patient with pneumocephalus caused by congenital mastoid dysplasia,and to clarify the clinical features,diagnostic methods and treatment strategies of intracranial accumulation of pneumocephalus.Methods:The patient with ineffective right upper limb activity accompanied stupid speech for 12 h was admitted to hospital.After admission,the head CT and MRI examination were performed again,and the patient was diagnosed as pneumocephalus.The paitent scheduled for stoma repair,neurotrophic treatment,infection prevention and other symptomatic treatments were performed after operation;the patient was instructed avoid cough forcefully,blowing nose,defecating and sneezing to increase the intracranial pressure.Results:Due to congenital dysplasia of mastoid wall,local thinning bones and intense swimming choking cough of the patient destroyed the intracranial pressure balance to form pneumocephalus,the patient scheduled for stoma and damaged dura repair;when discharged from hospital,the patient's right upper limb muscle strength and language function returned to normal;the head CT results showed that pneumocephalus disappeared completely.Conclusion;Pneumocephalus is common in clinic,and its reason is diversiform;it should be combined with the patient's history and imaging findings to explore the causes,the most reasonable treatment measures should be performed in order to relieve the patient's symptoms of increased intracranial pressure,and promote the recovery of neural function.

5.
Chinese Traditional and Herbal Drugs ; (24): 4215-4218, 2017.
Article in Chinese | WPRIM | ID: wpr-852455

ABSTRACT

Objective To study the chemical constituents of Glechoma longituba. Methods Chemical constituents were extracted by organic solvents, isolated and purified by chromatographic techniques with silica gel, Sephadex LH-20, semi-preparative HPLC, and recrystallization. Their structures were elucidated on the basis of physiochemical and spectral analyses. Results Thirteen compounds were obtained and elucidated as ursolic acid (1), asoleanolic acid (2), protocatechualdehyde (3), betulic acid (4), luteolin (5), β-sitosterol (6), lutin (7), syringic acid (8), 4-acetoxy-3,5-dimethoxybenzoicacid (9), 2,5-dihydroxy-1,4-benzenedicarboxylic acid (10), (E)-3-[4-(carboxymethoxy)-3-methoxyphenyl] acrylic acid (11), emodin (12), and loliolide (13). Conclusion Compounds 8-10 and 12 are isolated from this plant for the first time. Compounds 11 and 13 are isolated from the plants of Glechoma Linn. for the first time.

SELECTION OF CITATIONS
SEARCH DETAIL